Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Benvenuti

Showing results (11-20 of 334) with videos related to

Pageof 34
Sort By:
Minerva Ginecologica|September 29, 2012
Use of a lipid-lowering food supplement in patients on hormone therapy following breast cancerM Zanardi, E Quirico, C Benvenuti, et al.
International Journal of Clinical Pharmacology Research|January 1, 1983
Pharmacokinetics of cimetidine in patients with unresponsive duodenal ulcerV Rovati, D Foschi, C Benvenuti, et al.
Cancer Letters|September 1, 1983
H2 antagonists and therapy of rodent tumoursR Bossa, C Benvenuti, V Cantoni, et al.
International Journal of Tissue Reactions|January 1, 1983
Controlled study on flurbiprofen and diclofenac in the treatment of rheumatic disordersC Benvenuti, G Guidoni, A Longoni, et al.
Arzneimittel-Forschung|August 26, 1998
Pharmacodynamics and pharmacokinetics of pinacidil after a single dose of a new slow release tablet in healthy volunteersS R Bareggi, V Gambaro, M Valenti, et al.
Pharmatherapeutica|January 1, 1984
A multi-centre general practice study evaluating the efficacy and tolerance of ibuprofen in common painful conditionsC Benvenuti, A Beretta, A Longoni, et al.
Journal of Hepatology|November 1, 1996
Serum and urinary nitrate levels in liver cirrhosis: endotoxemia, renal function and hyperdynamic circulationB Campillo, P N Bories, C Benvenuti, et al.
Arzneimittel-Forschung|February 24, 1999
Pharmacodynamics and pharmacokinetics of pinacidil in normotensive volunteers after repeated doses of a new slow-release tablet formulationS R Bareggi, V Gambaro, M Valenti, et al.
Urology|September 1, 1994
Results of transurethral resection and intravesical doxorubicin prophylaxis in patients with T1G3 bladder cancerA V Bono, C Benvenuti, G Damiano, et al.
Arzneimittel-Forschung|June 1, 1997
Absorption of oral lornoxicam in healthy volunteers using a granular formulation in comparison with standard tabletsS R Bareggi, V Gambaro, M Valenti, et al.
Pageof 34

Showing results (11-20 of 334) with videos related to

Sort By:
Pageof 34
Minerva Ginecologica|September 29, 2012
Use of a lipid-lowering food supplement in patients on hormone therapy following breast cancerM Zanardi, E Quirico, C Benvenuti, et al.
International Journal of Clinical Pharmacology Research|January 1, 1983
Pharmacokinetics of cimetidine in patients with unresponsive duodenal ulcerV Rovati, D Foschi, C Benvenuti, et al.
Cancer Letters|September 1, 1983
H2 antagonists and therapy of rodent tumoursR Bossa, C Benvenuti, V Cantoni, et al.
International Journal of Tissue Reactions|January 1, 1983
Controlled study on flurbiprofen and diclofenac in the treatment of rheumatic disordersC Benvenuti, G Guidoni, A Longoni, et al.
Arzneimittel-Forschung|August 26, 1998
Pharmacodynamics and pharmacokinetics of pinacidil after a single dose of a new slow release tablet in healthy volunteersS R Bareggi, V Gambaro, M Valenti, et al.
Pharmatherapeutica|January 1, 1984
A multi-centre general practice study evaluating the efficacy and tolerance of ibuprofen in common painful conditionsC Benvenuti, A Beretta, A Longoni, et al.
Journal of Hepatology|November 1, 1996
Serum and urinary nitrate levels in liver cirrhosis: endotoxemia, renal function and hyperdynamic circulationB Campillo, P N Bories, C Benvenuti, et al.
Arzneimittel-Forschung|February 24, 1999
Pharmacodynamics and pharmacokinetics of pinacidil in normotensive volunteers after repeated doses of a new slow-release tablet formulationS R Bareggi, V Gambaro, M Valenti, et al.
Urology|September 1, 1994
Results of transurethral resection and intravesical doxorubicin prophylaxis in patients with T1G3 bladder cancerA V Bono, C Benvenuti, G Damiano, et al.
Arzneimittel-Forschung|June 1, 1997
Absorption of oral lornoxicam in healthy volunteers using a granular formulation in comparison with standard tabletsS R Bareggi, V Gambaro, M Valenti, et al.
Pageof 34